Discover the Innovative Sponsored Symposiums at the SOLACI-SBHCI 2023 Congress

Discover the innovative sponsored symposiums at the next SOLACI-SBHCI 2023 Congress.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-SBHCI 2023 | AORTIC ANEURYSM FROM THE GUIDELINES TO THE REAL WORLD – Dr. Felix Damas de los Santos

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Felix Damas de los Santos, entitled “Alternative Vascular...

SOLACI-SBHCI 2023 Scientific Coverage – Day 3

The third day of the Congress started at the Copacabana Arena with the International Live Case held at Nanjing First Hospital, Nanjing, China, which...

The former presidents of SOLACI and SBHCI received their well-deserved tribute during the SOLACI-SBHCI 2023 Congress

During the SOLACI-SBHCI 2023 Congress, a special session was held to honor the great figures of interventional cardiology in Brazil and Latin America, whose...

SOLACI Research Registries were presented at the SOLACI-SBHCI 2023 Congress

The area of records within SOLACI - SOLACI Research - continues to grow and share the results of its investigations with the entire Latin...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...